Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reducing frailty in frail people with multiple sclerosis: Feasibility of a 6-week multimodal exercise training program.

PloS oneĀ·2026
Same author

High-Intensity Functional Training for Older Adults with Mobility Disabilities: A Feasibility Pilot Study.

Healthcare (Basel, Switzerland)Ā·2026
Same author

Frailty, Disability, and Comorbidity in Multiple Sclerosis: Overlap and Distinct Associations with Quality of Life and Falls.

Multiple sclerosis and related disordersĀ·2026
Same author

Frailty and its association with mental health and quality of life in multiple sclerosis: A cross-sectional study.

Therapeutic advances in chronic diseaseĀ·2026
Same author

Clinicians' perspectives on the usability and usefulness of an mHealth fall risk assessment for individuals who use wheelchairs: a pilot study.

Disability and rehabilitation. Assistive technologyĀ·2025
Same author

Characterizing motoric cognitive risk syndrome beyond traditional criteria.

GeroScienceĀ·2025

Related Experiment Video

Updated: Jun 23, 2026

A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation tDCS in Multiple Sclerosis MS
08:18

A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation tDCS in Multiple Sclerosis MS

Published on: December 26, 2015

17.2K

Dry needling in multiple sclerosis: a scoping review.

Abbas Tabatabaei1,2, Farzan Molaei3, Tobia Zanotto4,5,6

  • 1Mobility and Falls Lab, Department of Physical Therapy, Rehabilitation Science, and Athletic Training, School of Health Professions, University of Kansas Medical Center, Kansas City, KS, USA.

Acupuncture in Medicine : Journal of the British Medical Acupuncture Society
|March 21, 2025
PubMed
Summary
This summary is machine-generated.

Dry needling (DN) may help reduce muscle spasticity in people with multiple sclerosis (pwMS). However, current evidence is limited, necessitating further high-quality research to confirm its effectiveness as an adjunct therapy.

Keywords:
dry needlingmobilitymultiple sclerosismuscle spasticitymyofascial trigger point

More Related Videos

Author Spotlight: Fu's Subcutaneous Needling for Knee Osteoarthritis Pain
07:19

Author Spotlight: Fu's Subcutaneous Needling for Knee Osteoarthritis Pain

Published on: March 24, 2023

4.3K
Author Spotlight: Unveiling the Therapeutic Effects of FSN Treatment – Bridging Research and Clinical Applications in Neuropathic Pain
08:20

Author Spotlight: Unveiling the Therapeutic Effects of FSN Treatment – Bridging Research and Clinical Applications in Neuropathic Pain

Published on: June 30, 2023

1.8K

Related Experiment Videos

Last Updated: Jun 23, 2026

A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation tDCS in Multiple Sclerosis MS
08:18

A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation tDCS in Multiple Sclerosis MS

Published on: December 26, 2015

17.2K
Author Spotlight: Fu's Subcutaneous Needling for Knee Osteoarthritis Pain
07:19

Author Spotlight: Fu's Subcutaneous Needling for Knee Osteoarthritis Pain

Published on: March 24, 2023

4.3K
Author Spotlight: Unveiling the Therapeutic Effects of FSN Treatment – Bridging Research and Clinical Applications in Neuropathic Pain
08:20

Author Spotlight: Unveiling the Therapeutic Effects of FSN Treatment – Bridging Research and Clinical Applications in Neuropathic Pain

Published on: June 30, 2023

1.8K

Area of Science:

  • Neurology
  • Rehabilitation Medicine
  • Physical Therapy

Background:

  • Muscle spasticity and mobility impairments are significant challenges for people with multiple sclerosis (pwMS).
  • Dry needling (DN) is being explored as a potential non-pharmacological intervention to manage these symptoms.

Purpose of the Study:

  • To systematically review the existing literature on the efficacy of dry needling (DN) for managing spasticity and improving mobility in people with multiple sclerosis (pwMS).

Main Methods:

  • A comprehensive literature search was conducted across multiple databases (PubMed, Scopus, etc.) and clinical trial registries.
  • Studies published between 2000 and 2023, involving DN for pwMS and excluding traditional medicine, were included.
  • Quality assessment of included studies was performed using Joanna Briggs Institute tools, with data extraction on spasticity, pain, mobility, and other outcomes.

Main Results:

  • Four case reports/series and one small randomized controlled trial (RCT) were identified.
  • Case reports/series consistently showed reduced spasticity following DN in pwMS.
  • The single RCT found no significant differences between DN and sham treatment; findings for other outcomes were mixed.

Conclusions:

  • Dry needling appears feasible and may offer potential benefits for spasticity management in pwMS, based on limited clinical observations.
  • The current evidence base is of low quality and quantity, primarily from uncontrolled studies.
  • High-quality research, including adequately powered RCTs, is essential to determine the true effectiveness of DN in the pwMS population.